- Home
- SPRY vs EVV Comparison
SPRY vs EVV Comparison
Compare SPRY & EVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SPRY | EVV |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2020 | 2003 |
Fundamental Metrics
Financial Performance| Metric | SPRY | EVV |
|---|---|---|
| Price | $9.19 | $9.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 299.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 114.04 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $89,149,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $119.97 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 297063.34 | N/A |
| 52 Week Low | $6.66 | $8.81 |
| 52 Week High | $18.63 | $10.41 |
Technical Indicators
Market Signals| Indicator | SPRY | EVV |
|---|---|---|
| Relative Strength Index (RSI) | 42.29 | 43.32 |
| Support Level | $8.61 | $9.84 |
| Resistance Level | $10.44 | $10.00 |
| Average True Range (ATR) | 0.50 | 0.04 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 35.48 | 18.05 |
Price Performance
Historical ComparisonAbout SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About EVV Eaton Vance Limited Duration Income Fund of Beneficial Interest
Eaton Vance Ltd Duration Income Fund is a diversified closed-end management investment company. The company's investment objective is to provide a high level of current income. The Fund also seeks capital appreciation. The Fund invests predominantly in Senior Floating-Rate Loans, Debt Obligations, Equity Securities, Derivatives as well as Foreign Securities and Currencies. The Fund invests in various industries, including aerospace and defense, automotive, building and development, healthcare, and leisure, among others.